US Patent 7700546 Therapeutic agent for cancer
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+384 characters)
Article
Patent abstract
The present invention provides a cancer therapeutic agent containing as an active ingredient a substance, particularly CRM197 which inhibits the binding of HB-EGF to EGF receptor by binding to HB-EGF, wherein a cancer is selected from the group consisting of a bladder cancer, a colon cancer or peritoneal metastatic cancers of a stomach cancer and a pancreatic cancer.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Eisuke Mekada0
Shingo Miyamoto0
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07700546 Therapeutic agent for cancer US Patent 7700546 Therapeutic agent for cancer
Infobox
Patent Number
07700546
Patent Number
7700546
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 4 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07700546 Therapeutic agent for cancer
Infobox
Is a
Patent jurisdiction
Patent number
07700546
Date of patent
April 20, 2010
Patent application number
11917706
Date Filed
June 20, 2006
Patent primary examiner
Find more entities like US Patent 7700546 Therapeutic agent for cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
